Hilltop National Bank increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 8,000.0% during the fourth quarter, HoldingsChannel reports. The fund owned 17,658 shares of the company’s stock after buying an additional 17,440 shares during the quarter. Hilltop National Bank’s holdings in GE HealthCare Technologies were worth $1,381,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Mesirow Financial Investment Management Inc. increased its holdings in GE HealthCare Technologies by 39.6% in the third quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock valued at $383,000 after purchasing an additional 1,159 shares during the period. LMR Partners LLP bought a new position in shares of GE HealthCare Technologies during the third quarter worth about $7,387,000. Principal Financial Group Inc. boosted its holdings in GE HealthCare Technologies by 1.9% in the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after acquiring an additional 19,010 shares during the last quarter. Everence Capital Management Inc. raised its holdings in GE HealthCare Technologies by 118.2% during the 4th quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock worth $1,475,000 after purchasing an additional 10,220 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $1,396,000. Institutional investors and hedge funds own 82.06% of the company’s stock.
GE HealthCare Technologies Price Performance
Shares of NASDAQ:GEHC traded down $1.32 on Friday, hitting $84.94. The company’s stock had a trading volume of 977,862 shares, compared to its average volume of 2,974,698. GE HealthCare Technologies Inc. has a 1 year low of $71.31 and a 1 year high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market capitalization of $38.81 billion, a PE ratio of 23.34, a PEG ratio of 2.90 and a beta of 1.11. The company has a 50-day simple moving average of $82.29 and a 200 day simple moving average of $84.05.
GE HealthCare Technologies Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is 3.85%.
Insider Transactions at GE HealthCare Technologies
In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.27% of the company’s stock.
Analyst Upgrades and Downgrades
GEHC has been the subject of a number of analyst reports. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their target price for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI lifted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday. One investment analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $96.00.
Read Our Latest Report on GEHC
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- The 3 Best Blue-Chip Stocks to Buy Now
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Retail Stocks Investing, Explained
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.